19 insiders have filed at ALKS since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Pops Richard F | Director And CEO, Alkermes Plc | 1.38M | 0.829% | ||
| Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | 281.7k | 0.17% | ||
| Jackson Blair Curtis | EVP, Chief Operating Officer | 241.3k | 0.145% | ||
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 235.6k | 0.142% | 2 sells $120k | |
| Brown Iain Michael | SVP, Chief Financial Officer | 148.2k | 0.089% | ||
| Nichols Christian Todd | SVP, Chief Commercial Officer | 109.8k | 0.066% | 5 sells $835k | |
| Daglio David Angelo JR. | Director | 107.8k | 0.065% | ||
| Cooke Shane | Director | 103.7k | 0.062% | 2 sells $2.1M | |
| Hopkinson Craig C. | EVP R&d, Chief Medical Officer | 89.4k | 0.054% | 19 sells $21.5M | |
| Mckeon Brian P | Director | 43.9k | 0.026% | ||
| Wysenski Nancy | Director | 31.6k | 0.019% | ||
| Snyderman Nancy Lynn Md | Director | 31.5k | 0.019% | ||
| Wilson Frank Anders | Director | 31.1k | 0.019% | ||
| Gaynor Richard | Director | 31.1k | 0.019% | ||
| Laurencin Cato T | Director | 29.1k | 0.018% | 2 sells $171k | |
| Alva Emily Peterson | Director | 27.3k | 0.016% | ||
| Wright Christopher I | Director | 23.0k | 0.014% | ||
| Lurker Nancy | Director | 10.7k | <0.01% | ||
| Parisi Samuel Joseph | VP, Finance (interim Pao) | 7.7k | <0.01% | 5 sells $523k |
Full register at boothcheck.com/insiders/ALKS. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.